VANESSA BRINK: Open Payments
NPI 1689234163 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,085 in 99 payments from 36 companies in 2025. Trend: 2023 $1,992 · 2024 $2,582 · 2025 $2,085
Food & beverage: $1,986Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $192 |
| ABBVIE INC. | 6 | $190 |
| E.R. Squibb & Sons, L.L.C. | 9 | $175 |
| Novartis Pharmaceuticals Corporation | 11 | $150 |
| Daiichi Sankyo Inc. | 6 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
| Celgene Corporation | 4 | $100 |
| PFIZER INC. | 4 | $70 |
| Janssen Biotech, Inc. | 3 | $69 |
| Gilead Sciences, Inc. | 2 | $53 |
Products named: KEYTRUDA, OPDIVO, IMBRUVICA, Enhertu, REBLOZYL, LIBTAYO, Fabhalta, Trodelvy.
Industry payments across GA — which companies pay providers there.
